国际口腔医学杂志 ›› 2022, Vol. 49 ›› Issue (2): 239-243.doi: 10.7518/gjkq.2022036
Xie Yongting(),Huang Ruijie,Zou Jing(
)
摘要:
低磷酸酯酶症是一种罕见的遗传性代谢性疾病。它是由于碱性磷酸酶基因突变导致体内其编码的组织非特异性碱性磷酸酶活性丧失或降低,从而引起无机焦磷酸盐在细胞外大量累积抑制骨骼和牙齿硬组织的矿化,进而导致骨骼和牙齿发育异常。低磷酸酯酶症的临床表现从仅表现为牙齿过早脱落,到严重的全身性骨骼形成不良。本文从低磷酸酯酶症患者的口腔表征入手,对其分类、诊断及鉴别诊断的研究进展进行综述,以期为口腔医生临床上早期正确诊断低磷酸酯酶症、给予患者恰当的治疗方案、提高其生存与生活质量提供参考。
中图分类号:
[1] |
Drake MT, Collins MT, Hsiao EC. The rare bone disease working group: report from the 2016 American society for bone and mineral research annual meeting[J]. Bone, 2017, 102: 80-84.
doi: 10.1016/j.bone.2017.01.021 |
[2] |
Bianchi ML, Bishop NJ, Guañabens N, et al. Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment[J]. Osteoporos Int, 2020, 31(8): 1445-1460.
doi: 10.1007/s00198-020-05345-9 pmid: 32162014 |
[3] |
Okawa R, Kokomoto K, Kitaoka T, et al. Japanese nationwide survey of hypophosphatasia reveals pro-minent differences in genetic and dental findings between odonto and non-odonto types[J]. PLoS One, 2019, 14(10): e0222931.
doi: 10.1371/journal.pone.0222931 |
[4] |
Hollis A, Arundel P, High A, et al. Current concepts in hypophosphatasia: case report and literature review[J]. Int J Paediatr Dent, 2013, 23(3): 153-159.
doi: 10.1111/j.1365-263X.2012.01239.x pmid: 22672232 |
[5] |
Vogt M, Girschick H, Schweitzer T, et al. Pediatric hypophosphatasia: lessons learned from a retrospective single-center chart review of 50 children[J]. Orphanet J Rare Dis, 2020, 15(1): 212.
doi: 10.1186/s13023-020-01500-x |
[6] |
Kiselnikova L, Vislobokova E, Voinova V. Dental manifestations of hypophosphatasia in children and the effects of enzyme replacement therapy on dental status: a series of clinical cases[J]. Clin Case Rep, 2020, 8(5): 911-918.
doi: 10.1002/ccr3.v8.5 |
[7] |
Feeney C, Stanford N, Lee S, et al. Hypophosphatasia and the importance of the general dental practitioner-a case series and discussion of upcoming treatments[J]. Br Dent J, 2018, 224(12): 937-943.
doi: 10.1038/sj.bdj.2018.441 |
[8] |
Bianchi ML. Hypophosphatasia: an overview of the disease and its treatment[J]. Osteoporos Int, 2015, 26(12): 2743-2757.
doi: 10.1007/s00198-015-3272-1 pmid: 26245849 |
[9] |
Taillandier A, Domingues C, Dufour A, et al. Gene-tic analysis of adults heterozygous for ALPL mutations[J]. J Bone Miner Metab, 2018, 36(6): 723-733.
doi: 10.1007/s00774-017-0888-6 pmid: 29236161 |
[10] |
Wenkert D, McAlister WH, Coburn SP, et al. Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature re-view)[J]. J Bone Miner Res, 2011, 26(10): 2389-2398.
doi: 10.1002/jbmr.v26.10 |
[11] |
Mornet E. Hypophosphatasia[J]. Metabolism, 2018, 82: 142-155.
doi: 10.1016/j.metabol.2017.08.013 |
[12] | Mornet E, Yvard A, Taillandier A, et al. A molecular-based estimation of the prevalence of hypophosphatasia in the European population[J]. Ann Hum Ge-net, 2011, 75(3): 439-445. |
[13] |
Fraser D. Hypophosphatasia[J]. Am J Med, 1957, 22(5): 730-746.
doi: 10.1016/0002-9343(57)90124-9 |
[14] |
Simon-Bouy B, Taillandier A, Fauvert D, et al. Hypophosphatasia: molecular testing of 19 prenatal cases and discussion about genetic counseling[J]. Prenat Diagn, 2008, 28(11): 993-998.
doi: 10.1002/pd.v28:11 |
[15] |
Whyte MP, Zhang F, Wenkert D, et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients[J]. Bone, 2015, 75: 229-239.
doi: 10.1016/j.bone.2015.02.022 |
[16] | Mori M, DeArmey SL, Weber TJ, et al. Case series: odontohypophosphatasia or missed diagnosis of ch-ildhood/adult-onset hypophosphatasia? Call for a long-term follow-up of premature loss of primary teeth[J]. Bone Rep, 2016, 5: 228-232. |
[17] |
Whyte MP. Hypophosphatasia: an overview for 2017[J]. Bone, 2017, 102: 15-25.
doi: 10.1016/j.bone.2017.02.011 |
[18] |
Takagi M, Kato S, Muto T, et al. Odontohypophosphatasia treated with asfotase alfa enzyme replacement therapy in a toddler: a case report[J]. Clin Pediatr Endocrinol, 2020, 29(3): 115-118.
doi: 10.1297/cpe.29.115 |
[19] |
Foster BL, Nagatomo KJ, Nociti FH Jr, et al. Central role of pyrophosphate in acellular cementum formation[J]. PLoS One, 2012, 7(6): e38393.
doi: 10.1371/journal.pone.0038393 |
[20] |
van den Bos T, Handoko G, Niehof A, et al. Cementum and dentin in hypophosphatasia[J]. J Dent Res, 2005, 84(11): 1021-1025.
pmid: 16246934 |
[21] |
Beertsen W, VandenBos T, Everts V. Root development in mice lacking functional tissue non-specific alkaline phosphatase gene: inhibition of acellular cementum formation[J]. J Dent Res, 1999, 78(6): 1221-1229.
pmid: 10371245 |
[22] | Hamada M, Okawa R, Matayoshi S, et al. Ankylosed primary molar in a Japanese child with hypophosphatasia[J]. Dent J (Basel), 2020, 9(1): 3. |
[23] |
Bloch-Zupan A, Vaysse F. Hypophosphatasia: oral cavity and dental disorders[J]. Arch Pediatr, 2017, 24(5S2): 5S80-5S84.
doi: 10.1016/S0929-693X(18)30020-4 |
[24] |
Whyte MP, Wenkert D, McAlister WH, et al. Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia[J]. J Bone Miner Res, 2009, 24(8): 1493-1505.
doi: 10.1359/jbmr.090308 |
[25] |
Hofmann CE, Harmatz P, Vockley J, et al. Efficacy and safety of asfotase alfa in infants and young children with hypophosphatasia: a phase 2 open-label study[J]. J Clin Endocrinol Metab, 2019, 104(7): 2735-2747.
doi: 10.1210/jc.2018-02335 |
[26] |
Mornet E, Taillandier A, Domingues C, et al. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation[J]. Eur J Hum Genet, 2021, 29(2): 289-299.
doi: 10.1038/s41431-020-00732-6 |
[27] | Sreeramulu B, Shyam ND, Ajay P, et al. Papillon-Lefèvre syndrome: clinical presentation and management options[J]. Clin Cosmet Investig Dent, 2015, 7: 75-81. |
[28] | Fageeh HN. Papillon-lefèvre syndrome: a rare case report of two brothers and review of the literature[J]. Int J Clin Pediatr Dent, 2018, 11(4): 352-355. |
[29] |
Haupt R, Minkov M, Astigarraga I, et al. Langerhans cell Histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years[J]. Pediatr Blood Cancer, 2013, 60(2): 175-184.
doi: 10.1002/pbc.24367 |
[30] |
Malech HL, Hickstein DD. Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency[J]. Curr Opin Hematol, 2007, 14(1): 29-36.
pmid: 17133097 |
[31] |
Whyte MP, Greenberg CR, Salman NJ, et al. Enzyme-replacement therapy in life-threatening hypophosphatasia[J]. N Engl J Med, 2012, 366(10): 904-913.
doi: 10.1056/NEJMoa1106173 |
[32] |
Bloch-Zupan A. Hypophosphatasia: diagnosis and clinical signs-a dental surgeon perspective[J]. Int J Paediatr Dent, 2016, 26(6): 426-438.
doi: 10.1111/ipd.12232 pmid: 27030892 |
[1] | 谢成佳, 葛少华. 牙骨质撕裂的诊治进展[J]. 国际口腔医学杂志, 2017, 44(3): 315-319. |
[2] | 陈甜,白丁. 骨硬化蛋白对牙骨质形成的影响及其机制[J]. 国际口腔医学杂志, 2016, 43(3): 333-337. |
[3] | 刘君瑜1 刘艳2 汪永跃3. 人牙周膜细胞在碱处理后的多孔钛表面的碱性磷酸酶活性测定[J]. 国际口腔医学杂志, 2015, 42(1): 12-15. |
[4] | 侯琳 马肃 陈力 陈蕊 刘培红 秦春林. 被动吸烟对鼠牙槽骨钙、磷含量及碱性磷酸酶活性的影响[J]. 国际口腔医学杂志, 2014, 41(5): 526-529. |
[5] | 陈杰 郭维华 田卫东. 牙囊和上皮根鞘细胞成无细胞牙骨质的机制[J]. 国际口腔医学杂志, 2014, 41(3): 314-319. |
[6] | 欧伟1 孙卫斌2. 牙骨质蛋白1的生物学作用及应用前景[J]. 国际口腔医学杂志, 2014, 41(2): 209-212. |
[7] | 任晓斌 和红兵 雷雅燕 张婉丽 张明珠. 云南白药对体外培养成骨细胞增殖分化的影响[J]. 国际口腔医学杂志, 2014, 41(1): 13-15. |
[8] | 郑桂婷 徐燕. WNT/β-连环蛋白信号转导通路在牙周组织再生中的作用[J]. 国际口腔医学杂志, 2013, 40(6): 773-777. |
[9] | 孙营营综述 林崇韬审校. 低碱性磷酸酯酶症及其在口腔中的表现[J]. 国际口腔医学杂志, 2011, 38(5): 581-583. |
[10] | 孙兰英1 王其宝1 包崇云2 葛文章1 杜毅1. 碱性磷酸酶mRNA 在体内组织工程骨中的表达[J]. 国际口腔医学杂志, 2011, 38(4): 388-391. |
[11] | 吴卫锋综述 郭淑娟 吴亚菲审校. 成牙骨质细胞的研究进展[J]. 国际口腔医学杂志, 2011, 38(1): 95-97. |
[12] | 杨力综述 蔡萍审校. 成牙骨质细胞培养方法的研究进展[J]. 国际口腔医学杂志, 2010, 37(01): 68-68~70. |
[13] | 王智, 靳淑梅综述 张君审校. 牙根吸收的原因与机制[J]. 国际口腔医学杂志, 2010, 37(01): 101-101~105. |
[14] | 席巧玲综述 陈智,张露审校. 牙周上皮剩余的研究进展[J]. 国际口腔医学杂志, 2009, 36(2): 205-205~207,210. |
[15] | 冯帆,汤炜,田卫东,. 牙周组织再生的调控机制[J]. 国际口腔医学杂志, 2008, 35(S1): -. |
|